Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
0.8425
-0.0064 (-0.75%)
At close: Oct 27, 2026, 4:00 PM EDT
0.8257
-0.0168 (-1.99%)
After-hours: Oct 27, 2026, 6:44 PM EDT
CNTB Stock Forecast
CNTB's stock price has decreased by -50.44% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 8 analysts polled by S&P Global, CNTB stock has a consensus rating of "Strong Buy" and an average price target of $5.88. The average 1-year stock price forecast is 597.92% higher than the current stock price, while the lowest is $4.00 (+374.78%) and the highest is $9.00 (+968.25%).
Price Target: $5.88 (+597.92%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for CNTB stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 6 | 7 | 7 | 7 | 7 |
| Buy | 0 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Initiates $4 | Buy | Initiates | $4 | +374.78% | Oct 12, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $7 | Buy | Reiterates | $7 | +730.86% | Oct 8, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $6 | Buy | Reiterates | $6 | +612.17% | Oct 1, 2026 |
| Lake Street | Lake Street | Buy Maintains $9 | Buy | Maintains | $9 | +968.25% | Sep 30, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $8 → $5 | Buy | Reiterates | $8 → $5 | +493.47% | Sep 22, 2026 |
Financial Forecast
Revenue This Year
7.29M
from 64.00K
Increased by 11,291.47%
Revenue Next Year
12.71M
from 7.29M
Increased by 74.30%
EPS This Year
-0.98
from -1.00
EPS Next Year
-0.77
from -0.98
EPS and Forward PE are based on non-GAAP adjusted numbers.